| 1. |
Korean Diabetes Association, Treatment Guideline for Diabetes, Korean Diabetes Association (2018), 13, 17
|
| 2. |
Jang HC, Choi SH, Characterization of Patients with Type 2 Diabetes according to Body Mass Index: Korea National Health and Nutrition Examination Survey from 2007 to 2011, Endocrinol Metab (2015), Vol 30, 514-521
|
| 3. |
Korean Obesity Association, Treatment Guideline for Obesity, Korean Obesity Association (2018), 17-18
|
| 4. |
Korean Diabetes Association, Diabetes Fact Sheet, Korean Diabetes Association (2018)
|
| 5. |
Torgerson JS, Hauptman J, Boldrin MN 외 1 명, XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients, Diabetes Care (2004), Vol 27, 155-161
|
| 6. |
Wing RR, Lang W, Wadden TA 외 3 명, et al., Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes, Diabetes Care (2011), Vol 34, 1481-1486
|
| 7. |
Kim DH, Park SC, Lee JH 외 3 명, et al., Recent Research Trends in Korean Medicine Treatment of Diabetes Mellitus - Focusing on Domestic Articles from 2008 to 2013 -, Korean Journal Orient Int Med (2013), Vol 4-3, 240-255
|
| 8. |
Hanefeld M, Fischer S, Schmechel H 외 3 명, et al., Diabetes Intervention Study, Multi-intervention trial in newly diagnosed NIDDM, Diabetes Care (1991), Vol 14, 308-317
|
| 9. |
United Kingdom Prospective Diabetes Study (UK-PDS), 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years, BMJ (1995), Vol 310, 83-88
|
| 10. |
Lee MJ, Kim SS, Management of Obesity in Patients with Diabetes Mellitus, Journal Korean Diabetes (2017), Vol 18, 229-238
|
| 11. |
Chon S, Park CY, Koh GP 외 3 명, et al., The Effect of Orlistat in Obese Patients with Type 2 Diabetes : Benefit on Abdominal Obesity and Glycemic Control, Journal Korean Med Obes Res (2004), Vol 13-4, 281-292
|
| 12. |
Lee EJ, Kim TN, Pharmacological Management of Obesity in Patients with Type 2 Diabetes: An Update, Korean Journal Obes (2016), Vol 25-3, 121-128
|
| 13. |
O’Neil PM, Smith SR, Weissman NJ 외 3 명, et al., Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study, Obesity (2012), Vol 20, 1426-1436
|
| 14. |
Hollander P, Gupta AK, Plodkowski R 외 3 명, et al., Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes, Diabetes Care (2013), Vol 36, 4022-4029
|
| 15. |
Davies MJ, Bergenstal R, Bode B 외 3 명, et al., Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE diabetes randomized clinical trial, JAMA (2015), Vol 314, 687-699
|
| 16. |
Han HJ, Kim HJ, Park EY 외 3 명, et al., The effect of oriental obesity therapy on Morbid obese patient with Type 2 Diabetes : Two Cases Report, Journal Korean Med (2010), Vol 10, 57-63
|
| 17. |
Kim HJ, Kim KS, Improvement of type 2 diabetes by very-low-calorie diet-A case report, Journal Korean Med (2002), Vol 2-1, 97-102
|
| 18. |
Cha YY, A case Study on the Treatment of Obese patient with diabetes, Journal Korean Med (2004), Vol 4-1, 193-199
|
| 19. |
World Health Organization-Uppsala Monitoring Centre (WHO-UMC), Causality categories [Internet], World Health Organization-Uppsala Monitoring Centre (WHO-UMC) (2018), https://who-umc.org/media/164200/who-umc-causality-assessment_new-logo.pdf
|
| 20. |
Korea Institute of Drug Safety & Risk Management, Adverse Drug Reaction Assessment Report. 1st ed, Korea Institute of Drug Safety & Risk Management (2013), 60-63
|
| 21. |
National Cancer Institute, National Institute of Health, U.S.DEPARTMENT OF HEALTH AND HUMAN SERVICES, Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0, National Cancer Institute, National Institute of Health, U.S.DEPARTMENT OF HEALTH AND HUMAN SERVICES (2010)
|
| 22. |
Basch E, Reeve B, Mitchell S 외 3 명, et al., Development of the National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (2014), Vol 106-9, 244
|
| 23. |
Korea Institute of Drug Safety & Risk Management, Terminology Guide for Reporting Adverse Drug Reactions, Korea Institute of Drug Safety & Risk Management (2014), 1-6
|
| 24. |
Lee JM, Longevity and life preservation in Eastern medicine, Haklimsa (1986), 333-338
|
| 25. |
Lee JE, Song YK, Lim HH, Clinical trial of Taeeumjowui-tang (Taiyintiaowei-tang) on obese patients: randomized, double blind, placebo-controlled study, Journal Orient Rehab Med (2010), Vol 20-4, 197-213
|
| 26. |
Lim SY, Park SW, Joo JH 외 3 명, The effects of Taeeumjowui-tang (Taiyintiaowei-tang) on obesity in Sasang constitution, Journal East-West Med (2012), Vol 37-4, 109-116
|
| 27. |
Park SJ, Nahmkoong W, Cheon CH 외 3 명, et al., Efficacy and safety of Taeeumjowi-tang in obese Korean adults: a double-blind, randomized, and placebo-controlled pilot trial, Evid-Based Complement Altern Med (2013), Vol 2013, 498935
|
| 28. |
Hwang MJ, Shin HD, Song MY, Literature review of herbal medicines on treatment of obesity since 2000; mainly about Ephedra Herba, Journal Korean Med Obes Res (2007), Vol 7-1, 39-54
|
| 29. |
Jang IS, Hwang EH, The Need for Clinical Practice Guidelines in Usage of Mahuang in Weight Loss, Journal Korean Med Obes Res (2007), Vol -1, 23-29
|
| 30. |
Jo GW, Ok JM, Kim SY 외 1 명, Review on the efficacy and safety of Mahuang and ephedrine in the treatment of obesity-focused on RCT, Journal Korean Med (2017), Vol 38-3, 170-184
|
| 31. |
Wing RR, Marcus MD, Epstein LH 외 1 명, A “family-based” approach to the treatment of of obese Type Ⅱ diabetic patients, Journal Consult Clin Psychol (1991), Vol 59, 156-162
|
| 32. |
Yoon NR, Yoo YJ, Kim MJ 외 3 명, et al., Analysis of Adverse Events in Weight Loss Program in Combination with ‘Gamitaeeumjowee-Tang’ and Low-Calorie Diet, Journal Korean Med Obes Res (2018), Vol 18-1, 1-9
|
| 33. |
Kim HJ, Kim JY, Clinical report about the adverse reactions of Taeeumin·Soeumin·Soyangin by Taeeumjowi-tang, Korean Journal Oriental Physiology & Pathology (2008), Vol 22-6, 1600-1605
|
| 34. |
Luyster FS, Dunbar-Jacob J, Sleep quality and quality of life in adults with type 2 diabetes, Diabetes Educ (2011), Vol 379, 347-355
|
| 35. |
Jain A, Sharmab R, Yadavc N 외 3 명, Quality of life and its association with insomnia and clinical variables in type 2 diabetes, Journal Egypt Public Health Assoc (2017), Vol 92-1, 52-59
|
| 36. |
Attarian H, Hachul H, Guttuso T 외 1 명, Treatment of chronic insomnia disorder in menopause: Evaluation of literature, Menopause (2015), Vol 22-6, 674-684
|
| 37. |
Kim Hwa, Diagnosis and Management of Diabetic Autonomic Neuropathy Chong, Journal Korean Diabetes (2018), Vol 19, 160-167
|
| 38. |
Christensen P, Bliddal H, Riecke BF 외 3 명, Comparison of a low-energy diet and a very low-energy diet in sedentary obese individuals: a pragmatic randomized controlled trial, Clin Obes (2011), Vol 1-1, 31-34
|
| 39. |
Kim JS, Yoon SH, Effect of Naesosan gastric motility between normal intact and antral dilatated rats, Journal Korean Orient Int Med (2008), Vol 29-1, 117-129
|